ST. LOUIS, MO, Euclises Pharmaceuticals, Inc., a biotechnology company developing novel COX-2 inhibitors for the treatment of cancer, today announced closing a $1.3 million Series A financing. Read More
BOSTON, MA, Biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, announced today that it has raised $40 million. Read More
NEW YORK, NY, Startup founded by former Google Creative Lab leads Jeff Baxter and Thomas Gayno, announced today the close of $1.8 million in seed round funding. Read More